55 related articles for article (PubMed ID: 34964038)
21. T-cell lymphoblastic lymphoma and leukemia: different diseases from a common premalignant progenitor?
Kroeze E; Loeffen JLC; Poort VM; Meijerink JPP
Blood Adv; 2020 Jul; 4(14):3466-3473. PubMed ID: 32722786
[TBL] [Abstract][Full Text] [Related]
22. Second malignant neoplasms after treatment of non-Hodgkin's lymphoma-a retrospective multinational study of 189 children and adolescents.
Attarbaschi A; Carraro E; Ronceray L; Andrés M; Barzilai-Birenboim S; Bomken S; Brugières L; Burkhardt B; Ceppi F; Chiang AKS; Csoka M; Fedorova A; Jazbec J; Kabickova E; Loeffen J; Mellgren K; Miakova N; Moser O; Osumi T; Pourtsidis A; Rigaud C; Uyttebroeck A; Woessmann W; Pillon M;
Leukemia; 2021 Feb; 35(2):534-549. PubMed ID: 32393843
[TBL] [Abstract][Full Text] [Related]
23. MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia.
Evensen NA; Madhusoodhan PP; Meyer J; Saliba J; Chowdhury A; Araten DJ; Nersting J; Bhatla T; Vincent TL; Teachey D; Hunger SP; Yang J; Schmiegelow K; Carroll WL
Haematologica; 2018 May; 103(5):830-839. PubMed ID: 29449434
[TBL] [Abstract][Full Text] [Related]
24. Results and conclusions of the European Intergroup EURO-LB02 trial in children and adolescents with lymphoblastic lymphoma.
Landmann E; Burkhardt B; Zimmermann M; Meyer U; Woessmann W; Klapper W; Wrobel G; Rosolen A; Pillon M; Escherich G; Attarbaschi A; Beishuizen A; Mellgren K; Wynn R; Ratei R; Plesa A; Schrappe M; Reiter A; Bergeron C; Patte C; Bertrand Y
Haematologica; 2017 Dec; 102(12):2086-2096. PubMed ID: 28983060
[TBL] [Abstract][Full Text] [Related]
25. Recognition of genetic predisposition in pediatric cancer patients: An easy-to-use selection tool.
Jongmans MC; Loeffen JL; Waanders E; Hoogerbrugge PM; Ligtenberg MJ; Kuiper RP; Hoogerbrugge N
Eur J Med Genet; 2016 Mar; 59(3):116-25. PubMed ID: 26825391
[TBL] [Abstract][Full Text] [Related]
26. Revised International Pediatric Non-Hodgkin Lymphoma Staging System.
Rosolen A; Perkins SL; Pinkerton CR; Guillerman RP; Sandlund JT; Patte C; Reiter A; Cairo MS
J Clin Oncol; 2015 Jun; 33(18):2112-8. PubMed ID: 25940716
[TBL] [Abstract][Full Text] [Related]
27. A Dutch Fanconi Anemia FANCC Founder Mutation in Canadian Manitoba Mennonites.
de Vries Y; Lwiwski N; Levitus M; Kuyt B; Israels SJ; Arwert F; Zwaan M; Greenberg CR; Alter BP; Joenje H; Meijers-Heijboer H
Anemia; 2012; 2012():865170. PubMed ID: 22701786
[TBL] [Abstract][Full Text] [Related]
28. Recurrent and founder mutations in the PMS2 gene.
Tomsic J; Senter L; Liyanarachchi S; Clendenning M; Vaughn CP; Jenkins MA; Hopper JL; Young J; Samowitz W; de la Chapelle A
Clin Genet; 2013 Mar; 83(3):238-43. PubMed ID: 22577899
[TBL] [Abstract][Full Text] [Related]
29. Somatic deletions of genes regulating MSH2 protein stability cause DNA mismatch repair deficiency and drug resistance in human leukemia cells.
Diouf B; Cheng Q; Krynetskaia NF; Yang W; Cheok M; Pei D; Fan Y; Cheng C; Krynetskiy EY; Geng H; Chen S; Thierfelder WE; Mullighan CG; Downing JR; Hsieh P; Pui CH; Relling MV; Evans WE
Nat Med; 2011 Sep; 17(10):1298-303. PubMed ID: 21946537
[TBL] [Abstract][Full Text] [Related]
30. Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults.
Murphy SB
Semin Oncol; 1980 Sep; 7(3):332-9. PubMed ID: 7414342
[No Abstract] [Full Text] [Related]
31. High Prevalence of Constitutional Mismatch Repair Deficiency in a Pediatric T-cell Lymphoblastic Lymphoma Cohort.
Kroeze E; Weijers DD; Hagleitner MM; de Groot-Kruseman HA; Jongmans MCJ; Kuiper RP; Pieters R; Meijerink JPP; Loeffen JLC
Hemasphere; 2022 Jan; 6(1):e668. PubMed ID: 34964038
[TBL] [Abstract][Full Text] [Related]
32. Acute lymphoblastic leukemia and lymphoma in the context of constitutional mismatch repair deficiency syndrome.
Ripperger T; Schlegelberger B
Eur J Med Genet; 2016 Mar; 59(3):133-42. PubMed ID: 26743104
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium 'care for CMMRD' (C4CMMRD).
Wimmer K; Kratz CP; Vasen HF; Caron O; Colas C; Entz-Werle N; Gerdes AM; Goldberg Y; Ilencikova D; Muleris M; Duval A; Lavoine N; Ruiz-Ponte C; Slavc I; Burkhardt B; Brugieres L;
J Med Genet; 2014 Jun; 51(6):355-65. PubMed ID: 24737826
[TBL] [Abstract][Full Text] [Related]
34. Immunotherapy holds the key to cancer treatment and prevention in constitutional mismatch repair deficiency (CMMRD) syndrome.
Westdorp H; Kolders S; Hoogerbrugge N; de Vries IJM; Jongmans MCJ; Schreibelt G
Cancer Lett; 2017 Sep; 403():159-164. PubMed ID: 28645564
[TBL] [Abstract][Full Text] [Related]
35. Connections between constitutional mismatch repair deficiency syndrome and neurofibromatosis type 1.
Wimmer K; Rosenbaum T; Messiaen L
Clin Genet; 2017 Apr; 91(4):507-519. PubMed ID: 27779754
[TBL] [Abstract][Full Text] [Related]
36. Constitutional mismatch repair deficiency as a differential diagnosis of neurofibromatosis type 1: consensus guidelines for testing a child without malignancy.
Suerink M; Ripperger T; Messiaen L; Menko FH; Bourdeaut F; Colas C; Jongmans M; Goldberg Y; Nielsen M; Muleris M; van Kouwen M; Slavc I; Kratz C; Vasen HF; Brugiѐres L; Legius E; Wimmer K
J Med Genet; 2019 Feb; 56(2):53-62. PubMed ID: 30415209
[TBL] [Abstract][Full Text] [Related]
37. Constitutional mismatch repair deficiency syndrome: clinical description in a French cohort.
Lavoine N; Colas C; Muleris M; Bodo S; Duval A; Entz-Werle N; Coulet F; Cabaret O; Andreiuolo F; Charpy C; Sebille G; Wang Q; Lejeune S; Buisine MP; Leroux D; Couillault G; Leverger G; Fricker JP; Guimbaud R; Mathieu-Dramard M; Jedraszak G; Cohen-Hagenauer O; Guerrini-Rousseau L; Bourdeaut F; Grill J; Caron O; Baert-Dusermont S; Tinat J; Bougeard G; Frébourg T; Brugières L
J Med Genet; 2015 Nov; 52(11):770-8. PubMed ID: 26318770
[TBL] [Abstract][Full Text] [Related]
38. The Challenge of Diagnosing Constitutional Mismatch Repair Deficiency Syndrome in Brain Malignancies from Young Individuals.
Carrato C; Sanz C; Muñoz-Mármol AM; Blanco I; Pineda M; Del Valle J; Dámaso E; Esteller M; Musulen E
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33924881
[TBL] [Abstract][Full Text] [Related]
39. Constitutional mismatch repair-deficiency: current problems and emerging therapeutic strategies.
Abedalthagafi M
Oncotarget; 2018 Oct; 9(83):35458-35469. PubMed ID: 30459937
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]